Pharmaceutical raw materials

Home - Products - Pharmaceutical raw materials

N-Acetyl-D-Glucosamine

  • Chemical raw materials, non-pharmaceuticals.
  • Product Name: N-Acetyl-D-Glucosamine
  • CasNo: 7512-17-6
  • Purity:
  • Appearance: white crystalline powder

Mobile/Wechat/WhatsApp: +447394406898

Email:wibson.aris@gmail.com

Inquiry

CasNo: 7512-17-6

Molecular Formula: C8H15NO6

Appearance: white crystalline powder

99% Purity Commercial production N-Acetyl-D-Glucosamine 7512-17-6 with Cheapest Price

  • Molecular Formula:C8H15NO6
  • Molecular Weight:221.21
  • Appearance/Colour:white crystalline powder 
  • Vapor Pressure:7.12E-19mmHg at 25°C 
  • Melting Point:211 °C (dec.)(lit.) 
  • Refractive Index:40.5 ° (C=1, H2O) 
  • Boiling Point:636.4 °C at 760 mmHg 
  • PKA:13.04±0.20(Predicted) 
  • Flash Point:338.7 °C 
  • PSA:127.09000 
  • Density:1.423 g/cm3 
  • LogP:-2.84410 

N-Acetyl-D-Glucosamine(Cas 7512-17-6) Usage

Description

N-Acetyl-D-Glucosamine (GlcNAc) is a monosaccharide derived from glucose.

Biochem/physiol Actions

N-Acetylglucosamine (GlcNAc) oligomer may have the ability to initiate factors for canine polymorphonuclear cells (PMN) in vivo. It possesses wound healing and chemotactic activity. GlcNAc and its derivatives are usually employed in preparing dietary supplements and also used in therapeutic development.

Sources

N-Acetylglucosamine (GlcNAc) is derived from chitin, the most abundant nitrogen-containing biopolymer on Earth. Chitin can be found in the exoskeletons of crustaceans and insects, as well as in fungal cell walls.[1]

Production Methods

Microbial fermentation, particularly using engineered strains of Corynebacterium glutamicum, has emerged as a promising method for GlcNAc production.[3]

Definition

ChEBI: The pyranose form of N-acetyl-D-glucosamine.

Uses

N-Acetyl-D-Glucosamine is commonly used for its anti-inflammatory properties in the treatment of osteoarthritis and inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. It plays a crucial role in bacterial metabolism and is a key structural component in polymers like chitin, as well as heterogenous polysaccharides like murein and hyaluronic acid. GlcNAc's anti-inflammatory effects are attributed to its ability to suppress IL-1β-induced production of nitric oxide, COX-2, and IL-6 by inhibiting iNOS expression. It is also utilized in pharmaceutical quality control as a secondary standard and as a calibration standard when diluted with water. Additionally, N-Acetyl-D-Glucosamine is a major component of bacterial cell walls and the extracellular matrix in animal cells, with a structure consisting of a glucose molecule linked to an N-acetyl group.

InChI:InChI=1/C8H15NO6/c1-4(12)9-5(2-10)7(14)8(15)6(13)3-11/h2,5-8,11,13-15H,3H2,1H3,(H,9,12)

7512-17-6 Relevant articles

Yeast-mycelial conversion induced by N-acetyl-D-glucosamine in Candida albicans

N. SIMONETTI, V. STRIPPOLI & A. CASSONE

, Nature volume 250, pages344–346 (1974)

DIMORPHISM in fungi is generally defined as a reversible transition from a yeast habit of growth (Y) to a mycelial one (M)1. In Candida albicans Y→M transition can occur rapidly in serum, serum substitutes and other natural4–6 and synthetic media. In a few hours the yeast cell or blastospore forms a germ tube which grows as a true mycelium.

Anti-tumor properties of orally administered glucosamine and N-acetyl-d-glucosamine oligomers in a mouse model

Sachie Masuda a , Kazuo Azuma a 1 , Seiji Kurozumi a , Masatoshi Kiyose a , Tomohiro Osaki a , Takeshi Tsuka a , Norihiko Itoh a , Tomohiro Imagawa a , Saburo Minami a , Kimihiko Sato b , Yoshiharu Okamoto a

, Carbohydrate Polymers Volume 111 , 13 October 2014, Pages 783-787

Previous reports have indicated that N-acetyl-d-glucosamine oligomer (NACOS) and glucosamine oligomer (COS) possess anti-tumor properties (Harish-Prashanth and Tharanathan, 2005, Huang et al., 2006, Shen et al., 2009; Suzuki et al., 1986, Tokoro et al., 1989, Wang et al., 2008). Furthermore, it was revealed that the tumor inhibitory effects of NACOS and COS are potentially related to their ability to induce lymphocyte cytokines thorough increased T-cell proliferation.

Biochemical Characterization and Structural Analysis of a β- N-Acetylglucosaminidase from Paenibacillus barengoltzii for Efficient Production of N-Acetyl- d -glucosamine

Liu, Yihao,Jiang, Zhengqiang,Ma, Junwen,Ma, Shuai,Yan, Qiaojuan,Yang, Shaoqing

, p. 5648 - 5657 (2020/06/03)

Bioproduction of N-acetyl-d-glucosamine ...

Synthesis and anticholinesterase activities of novel glycosyl benzoxazole derivatives

Cao, Zhi-Ling,Liu, Shu-Hao,Liu, Wei-Wei,Ren, Shu-Ting,Shi, Da-Hua,Wang, Lei,Wang, You-Xian,Wu, Yu-Ran

, p. 363 - 366 (2020/02/05)

Eight glycosyl benzoxazole derivatives a...

7512-17-6 Process route

3-O-{α-D-xylopyranosyl-(1→3)-α-L-arabinopyranosyl-(1→6)-[β-D-glucopyranosyl-(1→3)]-2-(acetamido)-2-deoxy-β-D-glucopyranosyl}echinocystic acid 28-O-{β-D-apiofuranosyl-(1→3)-β-D-xylopyranosyl-(1→2)-[2-O-cinnamoyl-α-L-arabinopyranosyl-(1→4)]-6-O-acetyl-β-D-glucopyranosyl} ester

3-O-{α-D-xylopyranosyl-(1→3)-α-L-arabinopyranosyl-(1→6)-[β-D-glucopyranosyl-(1→3)]-2-(acetamido)-2-deoxy-β-D-glucopyranosyl}echinocystic acid 28-O-{β-D-apiofuranosyl-(1→3)-β-D-xylopyranosyl-(1→2)-[2-O-cinnamoyl-α-L-arabinopyranosyl-(1→4)]-6-O-acetyl-β-D-glucopyranosyl} ester

D-xylose
58-86-6

D-xylose

D-apiose
639-97-4,6477-44-7,42927-70-8

D-apiose

L-arabinose
5328-37-0

L-arabinose

D-glucose
50-99-7

D-glucose

2-acetamido-2-deoxy-D-glucose
7512-17-6,282727-46-2,478518-83-1,127959-06-2,78393-48-3

2-acetamido-2-deoxy-D-glucose

echinocystic acid
510-30-5

echinocystic acid

Conditions
Conditions Yield
With hydrogenchloride; water; at 85 ℃; for 2h;
 
3-O-{α-D-xylopyranosyl-(1→3)-α-L-arabinopyranosyl-(1→6)-[β-D-glucopyranosyl-(1→3)]-2-(acetamido)-2-deoxy-β-D-glucopyranosyl}echinocystic acid 28-O-(β-D-apiofuranosyl-(1→3)-β-D-xylopyranosyl-(1→2)-{2-O-[(6S,2E)-2,6-dimethyl-6-hydroxy-2,7-octadienoyl]-α-L-arabinopyranosyl-(1→4)}-6-O-acetyl-β-D-glucopyranosyl) ester

3-O-{α-D-xylopyranosyl-(1→3)-α-L-arabinopyranosyl-(1→6)-[β-D-glucopyranosyl-(1→3)]-2-(acetamido)-2-deoxy-β-D-glucopyranosyl}echinocystic acid 28-O-(β-D-apiofuranosyl-(1→3)-β-D-xylopyranosyl-(1→2)-{2-O-[(6S,2E)-2,6-dimethyl-6-hydroxy-2,7-octadienoyl]-α-L-arabinopyranosyl-(1→4)}-6-O-acetyl-β-D-glucopyranosyl) ester

D-xylose
58-86-6

D-xylose

D-apiose
639-97-4,6477-44-7,42927-70-8

D-apiose

L-arabinose
5328-37-0

L-arabinose

D-glucose
50-99-7

D-glucose

2-acetamido-2-deoxy-D-glucose
7512-17-6,282727-46-2,478518-83-1,127959-06-2,78393-48-3

2-acetamido-2-deoxy-D-glucose

echinocystic acid
510-30-5

echinocystic acid

Conditions
Conditions Yield
With hydrogenchloride; water; at 85 ℃; for 2h;
 

7512-17-6 Upstream products

  • 108-24-7
    108-24-7

    acetic anhydride

  • 110-86-1
    110-86-1

    pyridine

  • 14131-64-7
    14131-64-7

    N-acetyl-D-mannosamine

  • 373-02-4
    373-02-4

    nickel diacetate

7512-17-6 Downstream products

  • 3946-01-8
    3946-01-8

    methyl N-acetyl-β-D-glucosaminide

  • 3615-17-6
    3615-17-6

    N-acetyl-D-mannosamine

  • 59445-85-1
    59445-85-1

    N-(furan-3-yl)acetamide

  • 63535-27-3
    63535-27-3

    2-acetylamino-D-erythro-2,3-dideoxy-hex-2c-enose

Leave Your Message

Relevant Products